WASHINGTON (AP) — The Food and Drug Administration announced Friday it will hold a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer’s anti-smoking ...

NEW YORK (Reuters Health) - In a trial among people with a history of depression, those taking the quit-smoking aid varenicline - marketed in the U.S. as Chantix - were no more prone to depression or ...

A popular drug prescribed to help people quit smoking may pose a significantly increased risk of heart attack in users, a new study finds. The results may further complicate doctors’ and patients’ ...

The Food and Drug Administration will allow Pfizer to remove a serious warning from the label of its anti-smoking drug Chantix, reports Fox News. While Chantix was approved 10 years ago, the FDA ...

WASHINGTON (Reuters) - Hundreds of patients taking Pfizer Inc's anti-smoking drug Chantix have reported serious accidents, vision problems and heart trouble, researchers said on Wednesday, sending ...

The Food and Drug Administration has been investigating reports of mood disorders and erratic behavior among Chantix patients since 2007. The agency said in a statement that two federally-funded ...

Kicking the habit can be hard enough, but smokers with depression face a steeper challenge. Now there’s evidence that the drug varenincline (Chantix) can help. About half of smokers who try to quit ...

WASHINGTON (AP) — Public safety advocates are asking the federal government to strengthen warnings on Pfizer’s anti-smoking drug Chantix, even as the drugmaker prepares to argue that a bold-letter ...

Pfizer Inc.’s stop-smoking pill Chantix has been linked to more than 3,000 reports in America of serious side effects, including suicides, heart trouble, and aggression, a study said. American ...

Several consumer groups have petitioned the FDA to increase the warnings about the controversial Chantix smoking-cessation drug, which has been linked to risks of suicidal behavior and hostility, ...